Prostate Cancer - Results from #23620

The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer - Abstract March 14, 2013

Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer - Abstract March 14, 2013

An anatomically realistic and adaptable prostate phantom for laser thermotherapy treatment planning - Abstract March 14, 2013

Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer - Abstract March 14, 2013

Prostate brachytherapy in men with gland volume of 100cc or greater: Technique, cancer control, and morbidity - Abstract March 14, 2013

Quality of life after radical radiotherapy for prostate cancer: Longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy - Abstract March 14, 2013

1.5-T magnetic resonance-guided transgluteal biopsies of the prostate in patients with clinically suspected prostate cancer: Technique and feasibility - Abstract March 14, 2013

A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy results - Abstract March 14, 2013

Impact of age at diagnosis on overall and disease-free survival in men with prostate cancer following conformal 3D radiation therapy - Abstract March 13, 2013

Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy - Abstract March 13, 2013

Four-year outcomes of hypofractionated high-dose-rate prostate brachytherapy and external beam radiotherapy - Abstract March 13, 2013

Short-term versus long-term hormone therapy plus radiotherapy or prostatectomy for prostate cancer: A systematic review and meta-analysis - Abstract March 13, 2013

Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: Model estimates of potential benefits and harms - Abstract March 13, 2013

Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer - Abstract March 13, 2013

Measuring symptoms in localized prostate cancer: A systematic review of assessment instruments - Abstract March 13, 2013

Monte Carlo simulations and radiation dosimetry measurements of (142)Pr capillary tube-based radioactive implant (CTRI): A new structure for brachytherapy sources - Abstract March 13, 2013

Bone Scan Index: A prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy - Abstract March 13, 2013

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: The randomised, phase 2 MRC PATCH trial (PR09) - Abstract March 13, 2013

Prostate cancer recurrence after radical prostatectomy: The role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging - Abstract March 12, 2013

A tailored prostate cancer education intervention for low-income African Americans: Impact on knowledge and screening - Abstract March 12, 2013

Page 1182 of 1435